Deep Knowledge Ventures investment remit includes artificial intelligence research and robotics, as well as longevity related biotechnology. On the subject of investment in pioneering technologies
Mr Kaminskiy said: “According to our estimates we are at an exciting historical point - even with a relatively small amount of investment - hundreds of millions of dollars - but with well-organized and inspired teams, it’s possible to accelerate the exponential growth in science and medicine.
Our first joint task is now to create a convenient format for investing in this field for conventional investors, who got used to think in very narrow categories. But we need to go beyond this and change the paradigm. Investors in this field stand to gain more valuable results than profit alone. The logic is effective: in case of successful investments, they automatically get direct access to the actual technologies of personalized medicine and life prolongation for themselves and their families. What other business could be better? When you prolong life and still earn a lot of money on this.
This is the same for all stakeholders. People engaged in charity get closer to the technologies of personalized medicine. Investors get even closer as they make money on it. In the forefront though are the entrepreneurs, who invest not only money - but also invest their infrastructure resources, time, expertise and managerial talent.
I estimate that the growth of the market for regenerative medicine is in a situation similar to the beginning of DotCom boom in the late 1990s. We can see it through big investments – Google with antiaging project – Calico, IBM with Watson, famous startup Human Longevity and even Lockheed Martin with their personalize
Copyright©2014 Vocus, Inc.
All rights reserved